Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DLX5 encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. Additionally we are shipping Distal-Less Homeobox 5 Kits (15) and Distal-Less Homeobox 5 Proteins (8) and many more products for this protein.
Showing 10 out of 108 products:
Human Polyclonal DLX5 Primary Antibody for ELISA, WB - ABIN451750
Lee, Kim, Kim, Park, Kang, Kyung, Sung, Wozney, Kim, Ryoo: BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. in The Journal of biological chemistry 2003
Show all 2 Pubmed References
Human Polyclonal DLX5 Primary Antibody for ICC, IF - ABIN4305382
Stadler, Rexhepaj, Singan, Murphy, Pepperkok, Uhlén, Simpson, Lundberg: Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. in Nature methods 2013
Our results in mice suggest that long-range DLX5 enhancer elements located in the human SLC25A13 (show slc25a13 Antibodies) gene may underlie the sensorineural hearing loss that is sometimes associated with SHFM1 (show SHFM1 Antibodies).
These results indicate activation of DLX5 and RUNX2 (show RUNX2 Antibodies) via its distal promoter represents a unique feature of GFs, and is important for ECM (show MMRN1 Antibodies) regulation. Down-regulation of these transcription factors in PAFs could be associated with their property to degrade collagen, which may impact on the process of periodontitis.
these findings indicate that, in MSCs, DLX5 is a master regulator of osteogenesis. Furthermore, tanshinone IIA may be valuable for stem cell-based therapies of certain bone diseases.
As a result of disturbed imprinting, the upregulated DLX5 affects trophoblast proliferation in preeclampsia.
These data indicate that certain missense mutations diminish the ability of the Dlx5 homeodomain to recognize and bind target DNAs, and they likely destabilize the formation of functional complexes.
In cells grown on titanium support, DLX5 and RUNX1 (show RUNX1 Antibodies) were respectively upregulated (+3.12-fold) and downregulated (-2.14-fold)
Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I.
Heterozygous DLX5 nonsense mutation c.G115T(p.E39X) associated with isolated split-hand/foot malformation with reduced penetrance and variable expressivity in two unrelated Polish families.
A novel heterozygous mutation in exon 3 of DLX5 found in the family members with SHFM1 (show SHFM1 Antibodies) phenotype.
Genome sequencing of the deletion breakpoints showed that the DLX5 and DLX6 genes are disomic but the putative DYNC1I1 (show DYNC1I1 Antibodies) exon 15 and 17 enhancers are deleted.
T-614 promotes osteoblastic differentiation by increasing the expression of Osterix (show SP7 Antibodies) and Dlx5.
Results indicate that Dlx5 and Runx2 (show RUNX2 Antibodies) are critical factors for the upregulated Osterix (show SP7 Antibodies) expression in shPP2A cells, which is considered to be important for the accelerated osteoblast differentiation in these cells.
FGF10 (show FGF10 Antibodies) pathway is downregulated in Dlx5(-/-) mice, and activation of FGF10 (show FGF10 Antibodies) signaling rescues cranial neural crest cell proliferation and myogenic differentiation.
High DLX5 expression is associated with T-cell lymphomagenesis.
Both transient and stable expression of Necdin (show NDN Antibodies) induced osteoblast-specific markers in an osteogenic cell line through formation of a complex with distal-less Homeobox 5 (Dlx5) and Runx2 (show RUNX2 Antibodies) promoter activation.
DLX5 and DLX6 reciprocally inhibit BMP/H2-mediated H1 enhancer regulation in mandible embryonic development.
We found that in Dlx5;6 DKO limbs, the AER expresses lower levels of Wnt5a (show WNT5A Antibodies), shows scattered beta-catenin (show CTNNB1 Antibodies) responsive cells and altered basolateral and planar cell polarity (PCP (show BMP1 Antibodies)).
Dlx5 and Dlx6 expression determines uterine architecture and adenogenesis and is needed for implantation
The results presented here indicate that loss of Dlx5 causes a down-modulation of miR (show MLXIP Antibodies)-9 and of miR (show MLXIP Antibodies)-200-class, which results in the over-expression of the Foxg1 (show FOXG1 Antibodies) protein.
Lck (show LCK Antibodies)-Dlx5 mice develop T-ALLs that consistently acquire overexpression of Myc (show MYC Antibodies) and activation of Akt (show AKT1 Antibodies).
Retinoic acid treatment leads to a progressive loss of Dlx5 and Dlx6 expression in the first pharyngeal arch.
Imprinting analysis shows that DLX5 is maternally expressed in some organs and tissues but not imprinted in others.
Data indicate that retinoic acid (RA) induces the expression patterns of genes normally expressed in the posterior tooth-forming region, such as pitx2 (show PITX2 Antibodies) and dlx2b.
This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein may play a role in bone development and fracture healing. Mutation in this gene, which is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 7, may be associated with split-hand/split-foot malformation.
distal-less homeo box 5
, homeobox protein DLX-5
, split hand/foot malformation type 1 with sensorineural hearing loss
, homeobox protein DLX-3
, homeobox protein DLL-3
, putative transcription factor DLL3
, distal-less homeobox 5
, distal-less homeobox protein 5
, distal-less homeobox gene 5
, distal-less homeobox protein 2b
, homeobox protein Dlx2b